Site #330 — Kansas City, Missouri

Site #330 is a clinical research site located in Kansas City, Missouri, United States 64154.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #330 has participated in 1 clinical trials.

Therapeutic areas: Presbyopia, Near Vision, Refractive Error.

Sponsors: LENZ Therapeutics, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

• Children's Mercy Hospital & Clinics
• Children's Mercy Hospital
• Children's Mercy Hospital - Department of Nephrology
• University of Kansas Medical Center
• University Of Kansas Cancer Center
• University of Missouri - Kansas City / The Children's Mercy Hospital
• University Health Truman Medical Center
• Children's Mercy Hospital/ID# 200221
• Saint Luke's Hospital/Marion Bloch Neuroscience Institute Dept of Regulatory
• VA Medical Center
• Saint Luke's Hospital of Kansas City Mid America
• Section of Pediatric Nephrology, Children's Mercy Hospitals and Clinics

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #330?

Site #330 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #330 conducted?

Site #330 has 1 clinical trials on record. Their work covers Presbyopia, Near Vision, Refractive Error.

Is Site #330 accredited by Crixeo Clinical Trials?

Site #330 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #330?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.